Bibliography: Scientific References and posters

AUTHORS : Andrian M. Benech Kieffer F. Dreher F Fouchard F Patouillet C Simonnet J T

Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or < alpha >-tocopherol applied on human skin models or human skin ex vivo at finite doses

2002 SKIN PHARMACOL APPL SKIN PHYSIOL. Skin Pharmacology and Applied Skin Physiology 2002 ;15 (Suppl. 1):40-58 | F. Dreher, L'Oreal Research, F-93601 Aulnay-sous-Bois EML: [email protected]

AUTHORS : Benech Kieffer F. Cottin M Dreher F Fouchard F Leclaire J Messager A Patouillet C Roguet R Zanini M

MODELS : EPISKIN

Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol

2002 Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):31-9 | L'Oreal Research, Aulnay-sous-Bois, France. [email protected]

AUTHORS : Bracher M Dami N Faller C Roguet R

MODELS : EPISKIN

APPLICATIONS : SKIN IRRITATION OF CHEMICALS

Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics

2002 Toxicol In Vitro 2002 ;16 (5):557-72 | Cosmital SA (Research Company of Wella AG, Germany), Rte de Chesalles 21, CH-1723 Marly, Switzerland. [email protected]

AUTHORS : Bracher M Faller C

MODELS : EPISKIN

APPLICATIONS : SKIN IRRITATION OF CHEMICALS

Reconstructed skin kits: reproducibility of cutaneous irritancy testing

2002 Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):74-91 | Cosmital SA (Research Company of Wella AG, Germany), Marly, Switzerland. [email protected]

AUTHORS : Botham Philip A

MODELS : EPISKIN

APPLICATIONS : OCULAR IRRITATION OF CHEMICAL Skin corrosion SKIN IRRITATION OF CHEMICALS

ECVAM, ECETOC and the EU Chemicals Policy. Alternatives to animal experiments: Progress made and challenges ahead. The proceedings of the ECVAM Status Seminar 2002, held on 4-6 June 2002, in the amphitheatre at the European Commission Joint Research Centr

2002 ATLA Alternatives to laboratory animals 2002 ;30 (SUP2):185-187 | Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, SK10 4TJ, United Kingdom

AUTHORS : Cohen C Grandidier M H Portes P Roguet R

MODELS : EPISKIN

APPLICATIONS : SKIN IRRITATION OF CHEMICALS

Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study

2002 Toxicol In Vitro 2002 Dec ;16 (6):765-70 | L'Oreal Recherche, Aulnay sous Bois, France. [email protected]

AUTHORS : Roguet R

MODELS : EPISKIN

The use of standardized human skin models for cutaneous pharmacotoxicology studies

2002 Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):1-3 | L'Oreal, Life Sciences, Advanced Research Laboratories, Clichy, France. [email protected]

AUTHORS : Boelsma E. Gibbs S Mommaas M Ponec M

MODELS : EPISKIN

Characterization of reconstructed skin models

2002 Skin Pharmacol Appl Skin Physiol 2002 ;15 (Suppl 1):4-17 | Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. [email protected]

AUTHORS : Benech-Kieffer F. Cottin M Dreher F Fouchard F Leclaire J Messager A Patouillet C Roguet R Zanini M

MODELS : EPISKIN

Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol

2002 Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1():31-39 | L'Oreal Research, Aulnay-sous-Bois, France. [email protected]

AUTHORS : Zuang V

MODELS : EPISKIN IRRISKIN

ECVAM's research and validation activities in the fields of topical toxicity and human studies

2002 Altern Lab Anim 2002 Dec ;30 Suppl 2):119-23 | ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy.

AUTHORS : Botham P A Briggs D Chesne C Elliott G R Fentem J H Harbell J W Heylings J R Portes P Roguet R van de Sandt J J

MODELS : EPISKIN

APPLICATIONS : SKIN IRRITATION OF CHEMICALS

A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team

2001 Toxicol In Vitro 2001 Feb ;15 (1):57-93 | Unilever Research, Colworth House, Sharnbrook, Bedfordshire MK44 1LQ, UK. [email protected]

AUTHORS : Catroux P Cotovio J Justine P Lamure S Onno L

MODELS : EPISKIN

Generation of oxidative stress in human cutaneous models following in vitro ozone exposure

2001 Toxicol In Vitro 2001 Aug-Oct ;15 (4-5):357-62 | L'OREAL Advanced Research, Life Sciences Division, 93600 Aulnay Sous Bois, France. [email protected]

AUTHORS : Cohen C Gagne C Leclaire J Roguet R Teissier M H Tessonneaud E

MODELS : EPISKIN

Use of a standardized reconstructed epidermis kit to assess in vitro the tolerance and the efficacy of cosmetics

2000 In vitro and molecular toxicology 2000 ;22 (6):409-419 | L'Oreal Life Science Research, 90 rue du general Roguet, 92583 Clichy, France; Episkin SNC ZI des Trocques, 69630 Chaponost, France

AUTHORS : Bellon-Fontaine M. N. Cohen C Cupferman S Lerebour G

MODELS : EPISKIN

Comparison of surface free energy between reconstructed human epidermis and in situ human skin

2000 Skin Res Technol 2000 Nov ;6 (4):245-249 | L'Oreal, Applied Research and Development, Microbiology Department, Chevilly-Larue; L'Oreal, Advanced Research Centre, Life Sciences, Aulnay-sous-bois; INRA, Bioadhesion and Material Hygiene Research Unit, Massy, France.

AUTHORS : Boelsma E. Ponec M Weerheim A

MODELS : EPISKIN

Covalently bound lipids in reconstructed human epithelia

2000 Acta Derm Venereol 2000 Mar-Apr ;80 (2):89-93 | Department of Dermatology, Leiden University Medical Center, The Netherlands. [email protected]

AUTHORS : Boelsma E. Mommaas M Mulder A Ponec M Weerheim A

MODELS : EPISKIN

Lipid and ultrastructural characterization of reconstructed skin models

2000 Int J Pharm 2000 Aug 10 ;203(1-2):211-225 | Sylvius Laboratory, Department of Dermatology, Leiden University Medical Center, P.O. Box 9503, 2300 RA, Leiden, The Netherlands. [email protected]

AUTHORS : Boelsma E. Faller C Gibbs S Ponec M.

MODELS : EPISKIN RHE / RECONSTRUCTED HUMAN EPIDERMIS

APPLICATIONS : SKIN IRRITATION OF CHEMICALS

Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation

2000 Acta Derm Venereol. 2000 Mar-Apr;80(2):82-8. | Department of Dermatology, Leiden University Medical Center, The Netherlands

AUTHORS : Castiel Higounenc I Ferraris C Gaetani Q Lavalle A Philippe M Schmidt L'Oreal R

MODELS : EPISKIN

Exogenous sphinganin derived sphingolipid increases epidermal ceramide content in human reconstructed skin

1999 Nouvelles Dermatologiques 1999 ;18 (8):541-546 | I. Castiel-Higounenc, Life Sci. Adv. Res. Ctr. C. Zviak, 90, rue du General Roguet, 92583 Clichy Cedex

AUTHORS : Cohen C Corsini E Galli C L Limiroli E Marinovich M Roguet R

MODELS : EPISKIN

Selective induction of interleukin-12 in reconstructed human epidermis by chemical allergens

1999 International journal of cosmetic science 1999 ;27 (2):261-269 | Center for Cosmetic Toxicology, Institute of Pharmacological Sciences, Via Balzaretti 9, 20133 Milan, Italy; Laboratoire de Recherche Fondamentale de L'Oreal, 93600 Aulnay-sous-Bois, France

AUTHORS : Duval C Regnier M Schmidt R

MODELS : EPISKIN

APPLICATIONS : SKIN IRRITATION OF CHEMICALS

Potential cosmetic applications of reconstructed epidermis

1999 Toxicology in vitro 1999 ;21 (1):51-58 | L'Oreal, Centre Charles ZVIAK, Life Science Research, 90 rue du General Roguet, 92583 Clichy, France